Delivery Order SPE2DR25D1106-SPE2DR26FJG2M
- Not listed
- The Defense Logistics Agency awarded a $29,696.06 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $49,813.65 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 17, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency has awarded a delivery order valued at $12,208.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $24,219.96 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). The contract utilizes firm fixed pricing with a non-competitive set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,570,268,300 units of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract. The award, made on December 12, 2025, carries a ceiling value of $4,324.62 and is scheduled for ultimate completion by December 15, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count) with a ceiling value of $24,362.76 under a firm fixed-price contract structure. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued against the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,170.28 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,313.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,812.86 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJG2MDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Jardiance 25 mg tablets (30-count packages) with a ceiling value of $1,077.32 and an ultimate completion date of January 7, 2026. This is a non-set-aside contract awarded through competitive procurement. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company operates as a subsidiary of Cencora, Inc., which also holds a significant IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. Jardiance, a diabetes medication, exemplifies the type of prescription pharmaceutical products that AmerisourceBergen routinely delivers under its federal contracts, supporting military treatment facilities and veteran healthcare programs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/5/26 |